4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-001617
Chief Legal Officer acquired 18,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derovan Netanel Chief Legal Officer | 2022-01-09 | Grant or award | +18,000 | 18,000 | D | ||
| Derivatives | |||||||
| Derovan Netanel Chief Legal Officer | 2022-01-09 | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | D | ||
Loading xslF345X03/ownership.xml…